Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2021-02-16 4:09 pm Purchase | 2020-12-31 | 13G | Revolution Medicines, Inc. RVMD | Third Rock Ventures III L.P. | 8,949,069 13.500% | 8,949,069 (New Position) | Filing History |
| 2021-02-16 3:00 pm Sale | 2020-12-31 | 13G | Revolution Medicines, Inc. RVMD | Cormorant Asset Management LP | 2,495,066 3.800% | -750,111 (-23.11%) | Filing History |
| 2021-02-12 6:25 pm Purchase | 2020-12-31 | 13G | Revolution Medicines, Inc. RVMD | The Column Group III, LP | 3,580,206 4.900% | 3,580,206 (New Position) | Filing History |
| 2021-02-11 10:46 am Purchase | 2020-02-13 | 13G | Fulcrum Therapeutics, Inc. FULC | Sanofi | 3,363,050 4.600% | 3,363,050 (New Position) | Filing History |
| 2021-02-10 11:47 am Purchase | 2020-12-31 | 13G | Revolution Medicines, Inc. RVMD | The Vanguard Group | 4,037,820 6.080% | 4,037,820 (New Position) | Filing History |
| 2021-02-08 10:31 am Purchase | 2021-02-05 | 13G | Revolution Medicines, Inc. RVMD | FMR LLC | 9,339,485 14.069% | 2,675,422 (+40.15%) | Filing History |
| 2021-02-02 3:13 pm Purchase | 2020-12-31 | 13G | Revolution Medicines, Inc. RVMD | BlackRock Inc. BLK | 3,512,087 5.300% | 3,512,087 (New Position) | Filing History |